Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Betsy Davis

Betsy Davis

Senior Strategic Marketing Manager

Connect with Betsy Davis on LinkedIn
Follow Betsy Davis on Twitter
Website:

About the author:

Betsy’s entire marketing career has exclusively focused on the STEM market, with a distinct emphasis on Pharma. During her tenure with Elsevier’s Corporate R&D group, she has managed market segmentation for the pharma and life sciences industry, and launched and manages The Hive, a partnership with a select group of biotech and pharmaceutical start-ups focused on early stage innovation in drug discovery and development. The program promotes collaboration and inspiration across the Pharma & Life Sciences industry. Prior to launching her marketing career, Betsy worked as a management consultant focused on strategy implementation. She holds an MBA from the University of Michigan’s Ross School of Business and a BA from Barnard College of Columbia University.


Posts by Betsy Davis

Artificial Intelligence Comes to the Life Sciences

Posted on September 18th, 2017 in Pharma R&D

Advances in neural network technology are making it possible to ‘teach’ machines more rapidly—and this machine learning can have big implications for the healthcare and life sciences industry. Continue reading “Artificial Intelligence Comes to the Life Sciences” »

Getting Personal: Better Diagnosis, Better Treatment

Posted on September 8th, 2017 in Pharma R&D

Figures released by the U.S. National Cancer Institute (NCI) in 2017 indicate that the burden of cancer is on the rise, with the number of diagnoses rising by 50% over the next 13 years. Even more troubling is the predicted mortality rate for cancer, Continue reading “Getting Personal: Better Diagnosis, Better Treatment” »

The Link Between Big Pharma and the Supplement Industry

Posted on July 28th, 2017 in Pharma R&D

When the FDA updated some of its guidelines around dietary supplements last year, many critics of the supplement (or “nutraceutical”) business were pleased to see a bit more regulation in an industry that enjoys surprisingly little oversight. Continue reading “The Link Between Big Pharma and the Supplement Industry” »

Maryland Attempts to Control Drug Prices

Posted on July 21st, 2017 in Pharma R&D

Consumer concerns over the price of drugs remain high, so it’s not surprising that Maryland recently passed a bill aimed at controlling costs. Continue reading “Maryland Attempts to Control Drug Prices” »

  1. 1
  2. 2
  3. 3
  4. 15